Side-by-side financials for FEMY and DXCM. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FEMY | DXCM |
|---|---|---|
| Market cap | - | $28.85 B |
| US-listed rank | - | #473 |
| Revenue (latest FY) | $2.29M | $4.66B |
| Net income (latest FY) | -$18.63M | $836.30M |
| Net margin | -812.3% | 17.9% |
| P/E (trailing FY) | - | 34.5 |
| SEC filings | 312 | 2,566 |
In their latest fiscal years, FEMASYS INC reported $2.29M in revenue while DEXCOM INC reported $4.66B.
Full pages: FEMASYS INC and DEXCOM INC, or browse the full rankings.